Identification of a new secretory factor, CCDC3/Favine, in adipocytes and endothelial cells

Biochemical and Biophysical Research Communications

Volumn 392, Issue 1, 2010, Pages 29-35

  Kobayashi, Sachiko ^a,b   Fukuhara, Atsunori ^a   Taguchi, Takashi ^a   Matsuda, Morihiro ^a,c   Tochino, Yoshihiro ^a   Otsuki, Michio ^a   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Adipocytes; Coiled coil domain containing 3 gene; Endothelial cells; Favine gene; Obesity

Indexed keywords

BREFELDIN A; DIMER; FAVINE; INSULIN; ISOPRENALINE; MESSENGER RNA; NORADRENALIN; PIOGLITAZONE; SECRETORY PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CCD3 GENE; CELL DIFFERENTIATION; CELL STRAIN COS7; CELL STRAIN HEPG2; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN GLYCOSYLATION; PROTEIN ISOLATION; RAT; SEQUENCE ALIGNMENT;

ADIPOCYTES; AMINO ACID SEQUENCE; ANIMALS; BLOOD VESSELS; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOTHELIUM, VASCULAR; GLYCOSYLATION; GOLGI APPARATUS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PROTEIN MULTIMERIZATION; PROTEINS;

MURINAE; MUS; RATTUS;

EID: 74849124892     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.142     Document Type: Article

References (33)

1. Funahashi T., Nakamura T., Shimomura I., et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern. Med. 38 (1999) 202-206
2. Matsuzawa Y., Funahashi T., Kihara S., et al. Adiponectin and metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 29-33
3. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol. Scand. 184 (2005) 285-293
4. Shimomura I., Funahashi T., Takahashi M., et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat. Med. 2 (1996) 800-803
5. Maeda K., Okubo K., Shimomura I., et al. Analysis of an expression profile of genes in the human adipose tissue. Gene 190 (1997) 227-235
6. Considine R.V., Sinha M.K., Heiman M.L., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334 (1996) 292-295
7. Spiegelman B.M., and Flier J.S. Obesity and the regulation of energy balance. Cell 104 (2001) 531-543
8. Muzzin P., Eisensmith R.C., Copeland K.C., et al. Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc. Natl. Acad. Sci. USA 93 (1996) 14804-14808
9. Maeda K., Okubo K., Shimomura I., et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun. 221 (1996) 286-289
10. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
11. Hotta K., Funahashi T., Arita Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1595-1599
12. Ouchi N., Ohishi M., Kihara S., et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 42 (2003) 231-234
13. Maeda N., Shimomura I., Kishida K., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8 (2002) 731-737
14. Hopkins T.A., Ouchi N., Shibata R., et al. Adiponectin actions in the cardiovascular system. Cardiovasc. Res. 74 (2007) 11-18
15. Ouchi N., and Walsh K. Adiponectin as an anti-inflammatory factor. Clin. Chim. Acta 380 (2007) 24-30
16. Matsuda M., Shimomura I., Sata M., et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J. Biol. Chem. 277 (2002) 37487-37491
17. Baumgartner-Parzer S.M., and Waldhausl W.K. The endothelium as a metabolic and endocrine organ: its relation with insulin resistance. Exp. Clin. Endocrinol. Diabetes 109 Suppl. 2 (2001) S166-S179
18. Alessi M.C., and Juhan-Vague I. PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2200-2207
19. Constans J., and Conri C. Circulating markers of endothelial function in cardiovascular disease. Clin. Chim. Acta 368 (2006) 33-47
20. Steinberg H.O., Chaker H., Leaming R., et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J. Clin. Invest. 97 (1996) 2601-2610
21. Okamoto Y., Kihara S., Ouchi N., et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106 (2002) 2767-2770
22. Tanabe A., Matsuda M., Fukuhara A., et al. Obesity causes a shift in metabolic flow of gangliosides in adipose tissues. Biochem. Biophys. Res. Commun. 379 (2009) 547-552
23. Kobayashi H., Matsuda M., Fukuhara A., et al. Dysregulated glutathione metabolism links to impaired insulin action in adipocytes. Am. J. Physiol. Endocrinol. Metab. 296 (2009) E1326-E1334
24. Susini C., Estival A., Scemama J.L., et al. Studies on human pancreatic acini: action of secretagogues on amylase release and cellular cyclic AMP accumulation. Pancreas 1 (1986) 124-129
25. Strausberg R.L., Feingold E.A., Grouse L.H., et al. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA 99 (2002) 16899-16903
26. Phillips T.E., and Frisch E.B. Secretory glycoconjugates of a mucin-synthesizing human colonic adenocarcinoma cell line. Analysis using double labeling with lectins. Histochemistry 93 (1990) 311-317
27. Goldstein I.J., and Hayes C.E. The lectins: carbohydrate-binding proteins of plants and animals. Adv. Carbohydr. Chem. Biochem. 35 (1978) 127-340
28. Juhan-Vague I., Alessi M.C., and Vague P. Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus. Ann. Med. 28 (1996) 371-380
29. Burkhard P., Stetefeld J., and Strelkov S.V. Coiled coils: a highly versatile protein folding motif. Trends Cell Biol. 11 (2001) 82-88
30. Nielsen B.B., Kastrup J.S., Rasmussen H., et al. Crystal structure of tetranectin, a trimeric plasminogen-binding protein with an alpha-helical coiled coil. FEBS Lett. 412 (1997) 388-396
31. 2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization. J. Biol. Chem. 284 (2009) 11942-11952
32. Kammerer R.A. Alpha-helical coiled-coil oligomerization domains in extracellular proteins. Matrix Biol. 15 (1997) 555-565 discussion 567-558
33. Hato T., Tabata M., and Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc. Med. 18 (2008) 6-14